NCT05736718

Brief Summary

This trial will compare two ways to improve communication about HPV vaccination in primary care. The research team will work with primary care clinics. Some clinics will receive communication training from an outside expert. Other clinics will receive the same training from a vaccine champion from their healthcare system.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 10, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 21, 2023

Completed
15 days until next milestone

Study Start

First participant enrolled

March 8, 2023

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

March 9, 2026

Status Verified

July 1, 2025

Enrollment Period

2.3 years

First QC Date

February 10, 2023

Last Update Submit

February 18, 2026

Conditions

Keywords

Human Papilloma Virusvaccinationadolescent medicineprimary careclinical champions

Outcome Measures

Primary Outcomes (1)

  • HPV vaccination (≥1 dose), 9-12 year olds

    Proportion of unvaccinated children who initiate the HPV vaccine series between baseline and 12-month follow-up, among those who were ages 9-12 at baseline

    from baseline to 12 months

Secondary Outcomes (1)

  • HPV vaccination (2 doses), 9-12 year olds

    from baseline to 12 months

Study Arms (2)

Champion AAT

EXPERIMENTAL

Staff in clinics randomized to this arm will receive an intervention called Announcement Approach Training (AAT). This training is designed to improve communication about HPV vaccination. The training will be organized and delivered by vaccine champions from participating healthcare systems.

Behavioral: Champion Announcement Approach Training

Traditional AAT

EXPERIMENTAL

Staff in clinics randomized to this arm will also receive Announcement Approach Training (AAT). The training will be organized and delivered by outside experts.

Behavioral: Traditional Announcement Approach Training

Interventions

AAT is a one-hour communication workshop that trains clinical staff how to recommend HPV vaccine for children ages 9-12. In the champion arm, vaccine champions will deliver the training using slides and a standardized script. They will also conduct outreach and sustainability planning.

Champion AAT

AAT is a one-hour communication workshop that trains clinical staff how to recommend HPV vaccine for children ages 9-12. In the traditional arm, outside experts will deliver the training using the same slides and script.

Traditional AAT

Eligibility Criteria

Age9 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Clinics are eligible if they:
  • provide primary care to children ages 9-12
  • specialize in pediatrics or family medicine
  • Children's medical records will be eligible to be included in the dataset if children:
  • are between the ages of 9-12 years at baseline
  • are attributed to a participating clinic at 12-month follow-up

You may not qualify if:

  • Clinics are excluded if they:
  • do not provide primary care to children ages 9-12
  • have a specialty other than pediatrics or family medicine
  • Children's medical records will be excluded if children:
  • are not between the ages of 9-12 years at baseline
  • are not attributed to a participating clinic at 12-month follow-up
  • are receiving hospice/palliative care, are pregnant, or have a history of HPV vaccine contraindications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599, United States

Location

University of Wisconsin - Madison

Madison, Wisconsin, 53726, United States

Location

Study Officials

  • Noel T Brewer, PhD

    University of North Carolina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: cluster randomized design in which clinics will be randomized within healthcare systems
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2023

First Posted

February 21, 2023

Study Start

March 8, 2023

Primary Completion

July 1, 2025

Study Completion

July 1, 2025

Last Updated

March 9, 2026

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations